WallStreetZenWallStreetZen

NASDAQ: CNTA
Centessa Pharmaceuticals PLC Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for CNTA

Based on 3 analysts offering 12 month price targets for Centessa Pharmaceuticals PLC.
Min Forecast
$4.00-11.11%
Avg Forecast
$4.83+7.4%
Max Forecast
$6.00+33.33%

Should I buy or sell CNTA stock?

Based on 3 analysts offering ratings for Centessa Pharmaceuticals PLC.
Hold
Strong Buy
0 analysts 0%
Buy
1 analysts 33.33%
Hold
1 analysts 33.33%
Sell
0 analysts 0%
Strong Sell
1 analysts 33.33%

Be the first to know when Wall Street analysts revise their CNTA stock forecasts and price targets.

CNTA stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
Goldman Sachs
Top 13%
88
HoldMaintains$4.500.00%2023-05-15
SVB Leerink
Top 6%
95
BuyInitiates Coverage On$6.00+33.33%2023-03-17
Morgan Stanley
Bottom 15%
15
Strong SellMaintains$4.00-11.11%2023-01-24

1 of 1

Forecast return on equity

Is CNTA forecast to generate an efficient return?
Company
N/A
Industry
0.1%
Market
71.95%

Forecast return on assets

Is CNTA forecast to generate an efficient return on assets?
Company
N/A
Industry
0.12%

CNTA vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
CNTA$4.50$4.83+7.40%Hold
ABUS$2.58$6.00+132.56%Strong Buy
BLTE$17.15$57.50+235.28%Strong Buy
ERAS$2.89$11.00+280.62%Strong Buy
AVTE$16.71$31.50+88.51%Strong Buy
View Top Biotech Stocks

Centessa Pharmaceuticals Stock Forecast FAQ

Is Centessa Pharmaceuticals Stock a good buy in 2023, according to Wall Street analysts?

The consensus among 3 Wall Street analysts covering (NASDAQ: CNTA) stock is to Hold CNTA stock.

Out of 3 analysts, 0 (0%) are recommending CNTA as a Strong Buy, 1 (33.33%) are recommending CNTA as a Buy, 1 (33.33%) are recommending CNTA as a Hold, 0 (0%) are recommending CNTA as a Sell, and 1 (33.33%) are recommending CNTA as a Strong Sell.

If you're new to stock investing, here's how to buy Centessa Pharmaceuticals stock.

What is CNTA's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: CNTA) forecast ROE is N/A, which is considered weak.

What is CNTA's Price Target?

According to 3 Wall Street analysts that have issued a 1 year CNTA price target, the average CNTA price target is $4.83, with the highest CNTA stock price forecast at $6.00 and the lowest CNTA stock price forecast at $4.00.

On average, Wall Street analysts predict that Centessa Pharmaceuticals's share price could reach $4.83 by May 15, 2024. The average Centessa Pharmaceuticals stock price prediction forecasts a potential upside of 7.4% from the current CNTA share price of $4.50.

What is CNTA's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: CNTA) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of 0.12%.
©2023 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTube
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.